PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2009 - 2013)
PharmaCyte Biotech's Return on Sales [ROS] came in at -40488.52% for fiscal Q1 2014 (quarter ended Jul 31, 2013), down 32357.12 percentage points from -8131.39% a year earlier and down 27450.43 percentage points from the prior quarter.
PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2009 - 2013) Analysis & Trends
For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech's Return on Sales [ROS] was -13851.65%, down 10923.11 percentage points from FY2012.
- Going back by fiscal year, Return on Sales [ROS] was -2928.55% in FY2012 (-2620.32 pp) and -308.23% in FY2011.
- The fiscal Q1 2014 figure represents the lowest quarterly Return on Sales [ROS] in data going back to fiscal Q1 2011.
- Year-over-year, Return on Sales [ROS] has declined for nine consecutive quarters, with an average year-over-year change of -7967.26 percentage points over the last eight quarters.
- The year-over-year drop in Return on Sales [ROS] has ranged between 1807.74 percentage points (fiscal Q3 2012) and 32357.12 percentage points (fiscal Q1 2014) over the last five years.
- Business Quant data shows PMCB's Return on Sales [ROS] at -13038.09% (Q4 2013), -8733.76% (Q3 2013) and -5547.89% (Q2 2013) in the three fiscal quarters before Q1 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | PharmaCyte Biotech | 4.29 Mn | -68.55 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2013 | -40,488.52% |
| Apr 30, 2013 | -13,038.09% |
| Jan 31, 2013 | -8,733.76% |
| Oct 31, 2012 | -5,547.89% |
| Jul 31, 2012 | -8,131.39% |
| Apr 30, 2012 | -7,227.51% |
| Jan 31, 2012 | -2,022.51% |
| Oct 31, 2011 | -2,034.52% |
| Jul 31, 2011 | -3,302.30% |
| Apr 30, 2011 | -432.24% |
| Jan 31, 2011 | -214.77% |
| Oct 31, 2010 | -120.85% |
| Jul 31, 2010 | -294.27% |
| Apr 30, 2010 | -5,138.18% |
| Jan 31, 2010 | -78.03% |
| Oct 31, 2009 | -690.29% |
| Jul 31, 2009 | -1,421.26% |
| Apr 30, 2009 | -5,727.23% |
| Jan 31, 2009 | -679.51% |
PharmaCyte Biotech Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();